Board Meetings for VENUSREM
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| VENUSREM | Venus Remedies Limited | 29 Oct 2024 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 29 Oct 2024 | Financial Results | To consider and approve the financial results for the period ended September 30, 2024 | |
| VENUSREM | Venus Remedies Limited | 13 Aug 2024 | Financial Results/Other business matters | To consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the period ended on 30th June 2024.2. To consider the appointment of independent director(s).3. To finalize the date of 35th Annual General Meeting of the company.4. Any other business with permission of the Chair. | |
| VENUSREM | Venus Remedies Limited | 13 Aug 2024 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business. | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 20 Jul 2024 | Board meeting Rescheduled | This is to inform you that the meeting of Board of Directors which was scheduled 20th July 2024 has been postponed till further notice due to non-availability of quorum..2. To finalize the date of 35th Annual General Meeting of the company.3. Any other business with permission of the Chair. has been postponed | |
| VENUSREM | Venus Remedies Limited | 20 Jul 2024 | Other business matters | 1. To consider the appointment of independent director.2. To finalize the date of 35th Annual General Meeting of the company.3. Any other business with permission of the Chair. | |
| VENUSREM | Venus Remedies Limited | 20 Jul 2024 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 20-Jul-2024 to consider Other business. | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 30 May 2024 | Financial Results | To consider and approve the financial results for the period ended March 31, 2024 | |
| VENUSREM | Venus Remedies Limited | 30 May 2024 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 14 Feb 2024 | Financial Results | To consider and approve the financial results for the period ended December 31, 2023 | |
| VENUSREM | Venus Remedies Limited | 14 Feb 2024 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 09 Nov 2023 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 09-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Other business. | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 09 Nov 2023 | Financial Results | 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th September 2023.2. Any other business with the permission of Chair | |
| VENUSREM | Venus Remedies Limited | 14 Aug 2023 | VENUS REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 . | Board Meeting Intimation | |
| VENUSREM | Venus Remedies Limited | 14 Aug 2023 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |